Track the 메드팩토 share price and the full directors' dealings record of the company, a publicly traded company based in South Korea. Shares are quoted on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 메드팩토 has recorded 40 insider filings. Market capitalisation: €87.4bn. The latest transaction was disclosed on 6 March 2026 (Other). Among the most active insiders: 김성진. The full history is accessible without an account.
40
Insider Decl.
n/a
Thresholds
n/a
33 ops.
Buy Volume
n/a
n/a
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 28,286 of 29,062 companies
11.7
score / 100
Value
13
Quality
11
FCF yld-16%
Earn yld-15%
EV/EBITDA·
ROE-27%
Gross mgn9.9%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
메드팩토 es una empresa del sector sanitario y farmacéutico, que cotiza en el mercado XKRX. Se centra en el desarrollo de tratamientos innovadores para el cáncer.